PFE vs ABBV: Which Stock is Better?
Side-by-side comparison of Pfizer Inc and Abbvie Inc in 2026
PFE
Pfizer Inc
$25.65
ABBV
Abbvie Inc
$214.35
Key Metrics Comparison
| Metric | PFE | ABBV | Winner |
|---|---|---|---|
| Market Cap | $145.84B | $378.84B | ABBV |
| P/E Ratio | 14.91 | 161.17 | PFE |
| EPS (TTM) | $1.72 | $1.33 | PFE |
| Revenue Growth | -0.1% | 0.1% | ABBV |
| Gross Margin | 74.8% | 71.5% | PFE |
Analyze PFE
Full quant analysis
Analyze ABBV
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PFE or ABBV a better investment?
Comparing PFE and ABBV: Pfizer Inc has a market cap of $145.84B while Abbvie Inc has $378.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PFE and ABBV?
PFE (Pfizer Inc) and ABBV (Abbvie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PFE or ABBV?
Based on P/E ratios, PFE trades at a lower multiple (14.9x vs 161.2x).
Which is growing faster: PFE or ABBV?
ABBV has higher revenue growth at 0.1% vs -0.1% for PFE.
Which company is more profitable: PFE or ABBV?
Pfizer Inc (PFE) has higher gross margins at 74.8% compared to 71.5% for ABBV.
Which is the larger company: PFE or ABBV?
Abbvie Inc (ABBV) is larger with a market cap of $378.84B compared to $145.84B for PFE.
Should I buy PFE or ABBV in 2026?
Both PFE and ABBV have investment merit. PFE trades at $25.65 while ABBV trades at $214.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PFE and ABBV stock?
Key differences: Market Cap ($145.84B vs $378.84B), P/E Ratio (14.9x vs 161.2x), Revenue Growth (-0.1% vs 0.1%), Gross Margin (74.8% vs 71.5%).